- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
Data from Public Health England (PHE), published as a pre-print, has shown that two doses of the Oxford/AstraZeneca vaccine were 92% effective against hospitalisation from infection with Delta variant (B.1.617.2), and no deaths were observed among those vaccinated. The vaccine was also effective against the Alpha variant (B.1.1.7) with an 86% reduction of hospitalisations and no deaths.
Additional data provided by
English
Japanese
